Four Stocks That Stand Out in Biotech's Bargain Bin

It's time to go hunting in the biotech bargain bin.

While the broad Amex Biotechnology Index can't seem to put any real distance from its year lows set in April, there are some decent buys to be found if you look closely. Fair-weather biotech investors have been scared off, leaving some fundamentally sound stocks bruised but not beaten. Call them biotech bargains because fund managers are finding the low prices irresistible.

Here are four such biotech bargains, all on the buy list of various fund managers, especially at current market prices -- Praecis Pharmaceuticals(PRCS Quote), Inhale Therapeutic(INHL Quote), Bio-Technology General(BTGC Quote), Interneuron(IPIC Quote). ...